MCID: PYL004
MIFTS: 33

Pyelitis

Categories: Nephrological diseases

Aliases & Classifications for Pyelitis

MalaCards integrated aliases for Pyelitis:

Name: Pyelitis 12 44 15 73

Classifications:



External Ids:

Disease Ontology 12 DOID:2744
ICD10 33 N12
MeSH 44 D011702
NCIt 50 C34964
SNOMED-CT 68 27174002
UMLS 73 C0034183

Summaries for Pyelitis

MalaCards based summary : Pyelitis is related to cystitis and pyelonephritis. An important gene associated with Pyelitis is NEXMIF (Neurite Extension And Migration Factor), and among its related pathways/superpathways are Bacterial infections in CF airways and Spinal Cord Injury. The drugs Cefixime and Ceftriaxone have been mentioned in the context of this disorder. Affiliated tissues include kidney, skin and bone.

Wikipedia : 76 Pyelonephritis is inflammation of the kidney, typically due to a bacterial infection. Symptoms most... more...

Related Diseases for Pyelitis

Diseases related to Pyelitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 129)
# Related Disease Score Top Affiliating Genes
1 cystitis 30.7 CRP CXCL8 IL6 TLR4
2 pyelonephritis 30.3 CRP CXCL8 CXCR1 IL6 TLR4
3 acute cystitis 30.1 CRP CXCL8 IL6
4 appendicitis 29.8 CRP CXCL8 IL6
5 acute pyelonephritis 29.7 CRP CXCL8 CXCR1 IL6
6 chlamydia pneumonia 10.3 CPN1 CRP
7 orthostatic proteinuria 10.2 B2M REN
8 dental abscess 10.2 CRP TLR4
9 amyloidosis aa 10.2 B2M CRP
10 cystitis cystica 10.2
11 cold agglutinin disease 10.2 CRP IL6
12 suppurative otitis media 10.2 CRP TLR4
13 pleural empyema 10.2 CRP P3H2
14 cryopyrin-associated periodic syndrome 10.2 CRP IL6
15 acute cholangitis 10.2 CRP IL6
16 acute adrenal insufficiency 10.1 IL6 REN
17 extramedullary plasmacytoma 10.1 B2M IL6
18 uremic pruritus 10.1 CRP IL6
19 neutrophilia, hereditary 10.1 CRP IL6
20 myasthenic syndrome, congenital, 1a, slow-channel 10.1 CRP CXCL8
21 spinal disease 10.1 CRP IL6
22 spondyloarthropathy 1 10.1 B2M CRP TLR4
23 pyuria 10.1 CRP CXCL8
24 viral pneumonia 10.1 CRP IL6
25 endocervicitis 10.1 PGPEP1 TLR4
26 multicentric castleman disease 10.1 CRP IL6
27 anterior uveitis 10.1 IL6 TLR4
28 cardiac rupture 10.1 CRP CXCL8
29 vesicoureteral reflux 1 10.1
30 hydronephrosis 10.1
31 pulmonary aspergilloma 10.1 CRP P3H2
32 relapsing polychondritis 10.1 CRP IL6
33 pouchitis 10.1 CXCL8 TLR4
34 central nervous system vasculitis 10.1 CRP IL6
35 apnea, obstructive sleep 10.1 CRP IL6 REN
36 subacute thyroiditis 10.1 CRP IL6
37 pericardial effusion 10.1 CRP IL6 REN
38 aortic disease 10.1 CRP IL6 REN
39 chronic pyelonephritis 10.1 B2M CPN1 NEXMIF TLR4
40 arteries, anomalies of 10.1 CRP IL6 REN
41 intussusception 10.1 CRP IL6
42 glucose metabolism disease 10.1 CRP IL6 REN
43 acquired metabolic disease 10.0 CRP IL6 REN
44 extrinsic cardiomyopathy 10.0 CRP IL6 TLR4
45 typhoid fever 10.0 CRP IL6 TLR4
46 al amyloidosis 10.0 B2M LYZ
47 recurrent corneal erosion 10.0 CXCL8 IL6
48 blue toe syndrome 10.0 CRP LYZ
49 bagassosis 10.0 CXCL8 IL6
50 superficial urinary bladder cancer 10.0 CXCL8 TLR4

Graphical network of the top 20 diseases related to Pyelitis:



Diseases related to Pyelitis

Symptoms & Phenotypes for Pyelitis

Drugs & Therapeutics for Pyelitis

Drugs for Pyelitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 101)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cefixime Approved, Investigational Phase 4 79350-37-1 5362065 54362
2
Ceftriaxone Approved Phase 4,Phase 3 73384-59-5 5479530 5361919
3
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2 85721-33-1 2764
4
Ofloxacin Approved Phase 4,Phase 3,Phase 2 82419-36-1 4583
5
Levofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2 100986-85-4 149096
6
leucovorin Approved Phase 4,Phase 3 58-05-9 6006 143
7
Trimethoprim Approved, Vet_approved Phase 4,Phase 3 738-70-5 5578
8
Nitrofurantoin Approved, Vet_approved Phase 4,Phase 3 67-20-9 5353830
9
Sulfamethoxazole Approved Phase 4,Phase 3 723-46-6 5329
10
Amoxicillin Approved, Vet_approved Phase 4,Phase 3 26787-78-0 33613
11
Cephalexin Approved, Investigational, Vet_approved Phase 4 15686-71-2 27447
12
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3 59-30-3 6037
13 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Not Applicable
14 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Not Applicable
15 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Not Applicable
16 Antitubercular Agents Phase 4,Phase 3,Not Applicable
17 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2
18 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 2
19 Fluoroquinolones Phase 4,Phase 2
20 Cytochrome P-450 CYP1A2 Inhibitors Phase 4,Phase 3,Phase 2
21 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 2
22 Anti-Infective Agents, Urinary Phase 4,Phase 3,Phase 2
23 Renal Agents Phase 4,Phase 3,Phase 2
24 Vitamin B9 Phase 4,Phase 3
25 Antiparasitic Agents Phase 4,Phase 3
26 Folic Acid Antagonists Phase 4,Phase 3
27 Vitamin B Complex Phase 4,Phase 3
28 Antimalarials Phase 4,Phase 3
29 Trimethoprim, Sulfamethoxazole Drug Combination Phase 4,Phase 3
30 Antiprotozoal Agents Phase 4,Phase 3
31 Folate Phase 4,Phase 3
32 Amdinocillin Pivoxil Phase 4
33
Edetic Acid Approved, Vet_approved Phase 3 62-33-9, 60-00-4 6049
34
Iron Approved Phase 3 7439-89-6 23925
35
Sulbactam Approved Phase 3,Phase 2 68373-14-8
36
Pentetic acid Approved Phase 3 67-43-6
37
Meropenem Approved, Investigational Phase 3,Phase 2 119478-56-7 64778 441130
38
Tazobactam Approved Phase 2, Phase 3,Phase 3 89786-04-9 123630
39
Fosfomycin Approved Phase 2, Phase 3 23155-02-4 446987
40
Piperacillin Approved Phase 2, Phase 3,Phase 3 66258-76-2 43672
41 Avibactam Approved Phase 3 1192500-31-4
42
Ceftazidime Approved Phase 3,Phase 2 78439-06-2, 72558-82-8 5481173
43
Tigecycline Approved Phase 3 220620-09-7 5282044
44
Colistin Approved Phase 3 1264-72-8, 1066-17-7 5311054
45
Minocycline Approved, Investigational Phase 3 10118-90-8 5281021
46
Cefepime Approved, Investigational Phase 3 88040-23-7 5479537
47
Ceftibuten Approved, Investigational Phase 3 97519-39-6 5282241 5282242
48 Omega 3 Fatty Acid Phase 3
49 carnitine Phase 3
50 beta-Lactamase Inhibitors Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 58)
# Name Status NCT ID Phase Drugs
1 Efficacy and Safety Study of Short-term Antibiotic for Pyelonephritis in Women Completed NCT01390623 Phase 4 Ceftriaxone
2 Treatment of Acute Pyelonephritis With Gram Negative Strains in Infants and Children Less Than 3 Years Old Completed NCT00136656 Phase 4 antibiotic;antibiotics
3 Pharmacokinetics of Ciprofloxacin in Pediatric Patients Completed NCT02598362 Phase 4 ciprofloxacin
4 Treatment's Duration of Acute Uncomplicated Pyelonephritis Completed NCT00873626 Phase 4 levofloxacin, ciprofloxacin and ofloxacin (fluoroquinolones)
5 A Randomized Controlled Trial on Antibiotic Prophylaxis in Children With Vesico-Ureteral Reflux Completed NCT00382343 Phase 4 Sulfamethoxazole/trimethoprim
6 Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication Completed NCT02246361 Phase 4
7 Impact on the Intestinal Microbiota of Treatment With Ceftriaxone in Women's Acute Community Pyelonephritis Recruiting NCT03179384 Phase 4 Ceftriaxone
8 Treating Pyelonephritis an Urosepsis With Pivmecillinam Recruiting NCT03282006 Phase 4 pivmecillinam
9 Management of Sub-Clinical Bacteriuria in Pregnancy Recruiting NCT03275623 Phase 4 Antibiotic
10 Safety and Efficacy Study of the Treatment of Kidney Infections With Short Course Levofloxacin Terminated NCT00239161 Phase 4 Levofloxacin
11 Oral Omega-3 for Reduction of Kidney Scar Due to Pyelonephritis in Children Unknown status NCT02192580 Phase 3 Omega-3
12 L-carnitine on the Prevention of Renal Scarring in Acute Pyelonephritis Unknown status NCT02007889 Phase 3 L-carnitine
13 CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria Completed NCT03477422 Phase 3 CSE-1034 (Ceftriaxone + Sulbactam + EDTA);Meropenem
14 Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections Completed NCT02753946 Phase 2, Phase 3 ZTI-01;Piperacillin-tazobactam
15 Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014) Completed NCT02728089 Phase 3 MK-7625A 1.5 g (ceftolozane 1 g/tazobactam 0.5 g)
16 A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP) Completed NCT02486627 Phase 3 plazomicin;meropenem;levofloxacin (oral)
17 Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP Completed NCT02166476 Phase 3 Meropenem-Vaborbactam;Piperacillin-Tazobactam;Levofloxacin;Saline
18 Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections) Completed NCT01599806 Phase 3 Ceftazidime - Avibactam ( CAZ-AVI);Doripenem;Either switch to oral therapy: 500 mg of Ciprofloxacin (oral);or switch to oral therapy: 800 mg/160 mg of sulfamethoxazole/trimethoprim (oral)
19 Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections) Completed NCT01595438 Phase 3 Ceftazidime - Avibactam ( CAZ-AVI);Doripenem;Either switch to oral therapy: 500 mg of Ciprofloxacin (oral);or switch to oral therapy: 800 mg/160 mg of sulfamethoxazole/trimethoprim (oral)
20 Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis Completed NCT01345929 Phase 3 CXA-201;Levofloxacin
21 Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis Completed NCT00229021 Phase 3 doripenum
22 Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis Completed NCT00210990 Phase 3 doripenem
23 A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated Urinary Tract Infection and Acute Pyelonephritis. Completed NCT00210886 Phase 3 levofloxacin
24 Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults Completed NCT02168946 Phase 3 Vabomere;Best Available Therapy
25 A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE) Completed NCT01970371 Phase 3 plazomicin;colistin;meropenem;tigecycline;antibiotic of Investigator's choice
26 A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections Completed NCT00258089 Phase 3 Levofloxacin
27 Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) Not yet recruiting NCT03788967 Phase 3 Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr);Ertapenem
28 Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) Not yet recruiting NCT03630081 Phase 3 FEP-TAZ 4 g;Meropenem;ciprofloxacin 500 mg Optional Oral Switch
29 A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections Terminated NCT01110408 Phase 3 Doripenem;Doripenem placebo;Cefepime;Cefepime placebo;Amoxicillin/clavulanate potassium
30 Short-term Antibiotic Therapy for Pyelonephritis in Childhood Terminated NCT00724256 Phase 3 ceftibuten;ceftibuten
31 Antibiotic Prophylaxis in Children With Pyelonephritis Withdrawn NCT00752375 Phase 3 Trimethoprim Sulfamethoxazole;placebo
32 Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli Unknown status NCT02537847 Phase 2 Sitafloxacin;Ertapenem
33 Evaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults With Complicated Urinary Tract Infections Completed NCT03445195 Phase 2 Sulbactam-ETX2514;Placebo;Imipenem-cilastatin
34 A Study of Efficacy/Safety of Intravenous S-649266 Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections Completed NCT02321800 Phase 2 S-649266;Imipenem/cilastatin
35 Effect of Acetylcysteine in Pediatric Acute Pyelonephritis. Completed NCT02080182 Phase 2 Acetylcysteine;placebo acetylcysteine
36 Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI) (MK-7655-003) Completed NCT01505634 Phase 2 MK-7655 250 mg;MK-7655 125 mg;imipenem/cilastatin 500 mg;Placebo to MK-7655;Ciprofloxacin
37 A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP) Completed NCT01096849 Phase 2 levofloxacin;plazomicin;placebo
38 Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections Completed NCT00921024 Phase 2 CXA-101;Ceftazidime
39 Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis Completed NCT01928433 Phase 2 Finafloxacin 800 mg i.v. once daily;Finafloxacin placebo i.v. once daily;Finafloxacin 800 mg tablets once daily;Finafloxacin placebo tablets once daily;Ciprofloxacin 400 mg i.v. twice daily;Ciprofloxacin placebo i.v. twice daily;Ciprofloxacin 500 mg oral twice daily;Ciprofloxacin placebo oral twice daily
40 IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis Recruiting NCT03757234 Phase 2 Omadacycline;Levofloxacin
41 MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034) Recruiting NCT03230838 Phase 2 Ceftolozane;Tazobactam;Meropenem
42 GSK2251052 in Complicated Urinary Tract Infection Terminated NCT01381549 Phase 2 GSK2251052;imipenem-cilastatin
43 Prospective Study in the Emergency Terminated NCT01628900 Phase 2
44 Dexamethasone Administration in 1st Episode of Febrile Urinary Tract Infection Unknown status NCT02034851
45 Antibiotic Treatment Versus no Therapy in Kidney Transplant Recipients With Asymptomatic Bacteriuria Unknown status NCT01771432 Not Applicable Antibiotic treatment
46 Proteinuria During Acute Pyelonephritis In Pregnancy Unknown status NCT02536638
47 Contrast-Enhanced US of Spleen, Liver and Kidney Unknown status NCT00190281
48 Kinetics of Biomarkers in Acute Pyelonephritis Completed NCT00805181
49 Risk Factors for Recurrent Urinary Tract Infection in Children Completed NCT00528476
50 Prospective Comparative Study About Treatment of Asymptomatic Bacteriuria in Kidney Transplant Recipients. Completed NCT02373085 Not Applicable

Search NIH Clinical Center for Pyelitis

Cochrane evidence based reviews: pyelitis

Genetic Tests for Pyelitis

Anatomical Context for Pyelitis

MalaCards organs/tissues related to Pyelitis:

41
Kidney, Skin, Bone, Heart, Lymph Node, Thyroid, B Cells

Publications for Pyelitis

Articles related to Pyelitis:

(show top 50) (show all 163)
# Title Authors Year
1
Air bubbles in the urinary tract. Incidental and asymptomatic combined emphysematous pyelitis, ureteritis and cystitis. A rare case report and review of the literature. ( 29785361 )
2018
2
Foley Follies: Emphysematous Pyelitis from Instrumentation in Obstructive Uropathy. ( 29098124 )
2017
3
Emphysematous Pyelitis: An Entity Distinct from Emphysematous Pyelonephritis. ( 28502342 )
2017
4
Emphysematous pyelitis and cystitis associated with vesicoureteral reflux in a diabetic dog. ( 27041755 )
2016
5
Pseudotuberculous Granulomatous Pyelitis: Report of a Case. ( 27440812 )
2016
6
Encrusted Uretero-pyelitis: Case Report. ( 27335796 )
2016
7
Appearance of Pyelitis Emphysematosa on Computed Tomography. ( 27993715 )
2016
8
Emphysematous cystitis with concomitant bilateral emphysematous ureteritis and pyelitis in a diabetic patient. ( 26175815 )
2015
9
"I have chicken fat in my urine!" A case of Candida tropicalis induced emphysematous pyelitis. ( 26909246 )
2015
10
Plagiarism in the article Emphysematous cystitis and emphysematous pyelitis: a clinically misleading association. Mustapha Ahsaini et al. The Pan African Medical Journal. 2013;16:18. (doi:10.11604/pamj.2013.16.18.2505). ( 26328003 )
2015
11
67Ga SPECT/CT of infected bladder stones and pyelitis. ( 25546213 )
2015
12
A Rare Case of Pneumoureter: Emphysematous Pyelitis versus Emphysematous Pyelonephritis. ( 26676155 )
2015
13
Emphysematous Pyelitis. ( 25266345 )
2014
14
Ileo-pelvic anastomosis and augmentation cystoplasty for treatment of encrusted pyelitis in a transplanted kidney. ( 23550263 )
2013
15
Bilateral emphysematous pyelitis: a rare encounter in urology. ( 24045515 )
2013
16
Emphysematous cystitis and emphysematous pyelitis: a clinically misleading association. ( 24498467 )
2013
17
Encrusted cystitis and pyelitis. ( 22616968 )
2012
18
Emphysematous urinoma as a complication of emphysematous pyelitis in a healthy adult male. ( 22739565 )
2012
19
Clinics in diagnostic imaging (138). Emphysematous pyelitis. ( 22434298 )
2012
20
Case 167: alkaline-encrusted pyelitis. ( 21339355 )
2011
21
Alkaline-encrusted pyelitis and cystitis: an easily missed and life-threatening urinary infection. ( 22700348 )
2011
22
Emphysematous pyelitis. ( 20231336 )
2010
23
Emphysematous pyelitis, ureteritis and cystitis. ( 21749809 )
2010
24
Emphysematous pyelitis. ( 20231342 )
2010
25
Chronic sclerosing pyelitis with an increased number of IgG4-positive plasma cells. ( 20033370 )
2009
26
Emphysematous pyelitis: epidemiological, therapeutic and evolutive features. ( 19537009 )
2009
27
Air in the kidney: between emphysematous pyelitis and pyelonephritis. ( 21611013 )
2008
28
Granulomatous pyelitis associated with urinary obstruction: a comprehensive clinicopathologic study. ( 16715072 )
2006
29
Alkaline encrusted pyelitis. ( 16502598 )
2005
30
Monolateral encrusted pyelitis in a double kidney transplanted patient. ( 15931651 )
2005
31
Encrusted cystitis and pyelitis in children: an unusual condition with potentially severe consequences. ( 15592084 )
2005
32
Successful treatment of encrusted cystitis and pyelitis with preservation of renal graft. ( 15280698 )
2004
33
Encrusted cystitis and pyelitis in children: an unusual condition with potentially severe consequences. ( 15351595 )
2004
34
Renal pelvic wall thickening in childhood urinary tract infections--evidence of acute pyelitis or vesicoureteral reflux? ( 12745739 )
2003
35
Bilharzial pyelitis: a rare cause of secondary ureteropelvic junction obstruction. ( 14532820 )
2003
36
Mortality from grossly encrusted bilateral pyelitis, ureteritis, and cystitis by Corynebacterium group D2. ( 12597981 )
2003
37
Emphysematous pyelitis presenting as an acute abdomen in an end-stage renal disease patient treated with peritoneal dialysis. ( 14558537 )
2003
38
Emphysematous pyelitis presenting as an acute abdomen in an end-stage renal disease patient treated with peritoneal dialysis. ( 12324934 )
2002
39
ED ultrasound: emphysematous pyelitis. ( 12098188 )
2002
40
Imaging characteristics of alkaline-encrusted cystitis and pyelitis. ( 11804900 )
2002
41
Encrusted cystitis and pyelitis. ( 11306884 )
2001
42
Emphysematous pyelitis: findings in five patients. ( 11230634 )
2001
43
Renal scan in emphysematous pyelitis. ( 11711715 )
2001
44
Encrusted pyelitis: an underdiagnosed condition? ( 10862627 )
2000
45
Hemorrhagic pyelitis, ureteritis, and cystitis secondary to cyclophosphamide: case report and review of the literature. ( 10637075 )
2000
46
Encrusted pyelitis of native kidneys. ( 10820179 )
2000
47
The conservative management of corynebacterium group D2 encrusted pyelitis. ( 10468720 )
1999
48
Successful treatment of encrusted pyelitis in a renal transplant with local acidification and surgical ileocaliceal anastomosis. ( 10492200 )
1999
49
Encrusted cystitis and pyelitis. ( 9628593 )
1998
50
Pyelitis cystica. ( 9406318 )
1997

Variations for Pyelitis

Expression for Pyelitis

Search GEO for disease gene expression data for Pyelitis.

Pathways for Pyelitis

GO Terms for Pyelitis

Cellular components related to Pyelitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.5 B2M CPN1 CRP CXCL8 IL6 LYZ
2 extracellular region GO:0005576 9.23 B2M CPN1 CRP CXCL8 IL6 LYZ

Biological processes related to Pyelitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cellular response to lipopolysaccharide GO:0071222 9.61 CXCL8 IL6 TLR4
2 defense response to Gram-positive bacterium GO:0050830 9.5 CRP IL6 LYZ
3 defense response to Gram-negative bacterium GO:0050829 9.43 IL6 LYZ TLR4
4 positive regulation of chemokine production GO:0032722 9.4 IL6 TLR4
5 response to molecule of bacterial origin GO:0002237 9.37 B2M CXCL8
6 immune response GO:0006955 9.35 B2M CXCL8 CXCR1 IL6 TLR4
7 negative regulation of lipid storage GO:0010888 9.16 CRP IL6
8 inflammatory response GO:0006954 9.02 CRP CXCL8 IL6 LYZ TLR4

Sources for Pyelitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....